Skip to main content
AVACTA GROUP PLC logo

AVACTA GROUP PLC — Investor Relations & Filings

Ticker · AVCT ISIN · GB00BYYW9G87 LEI · 2138009U3EG31OPMGH36 IL Manufacturing
Filings indexed 708 across all filing types
Latest filing 2020-06-09 Regulatory Filings
Country GB United Kingdom
Listing IL AVCT

About AVACTA GROUP PLC

https://avacta.com/

Avacta Group PLC is a clinical-stage biotechnology company developing targeted oncology drugs. The company's core technology is the proprietary pre|CISION® platform, a drug delivery system designed to improve the safety and efficacy of potent cancer therapies. The platform works by linking a peptide to a cancer drug, rendering it inactive in the bloodstream. The drug is precisely activated only within the tumor microenvironment by the Fibroblast Activation Protein (FAP) enzyme, which is abundant in many solid tumors. This approach aims to concentrate the active therapy at the tumor site, thereby reducing systemic toxicity and improving the therapeutic window for patients. The company is advancing a pipeline of peptide drug conjugates (PDCs) based on this platform.

Recent filings

Filing Released Lang Actions
Update on COVID-19 Test Development with Adeptrix
Regulatory Filings Classification · 98% confidence The document begins with 'RNS Number : 3248P' and concludes with information about RNS, the news service of the London Stock Exchange, stating it is an 'approved Primary Information Provider'. The content is a press release announcing an update on a COVID-19 diagnostic test development, which is a typical corporate announcement. Since this is a general regulatory announcement disseminated via the RNS system and does not fit neatly into specific financial report categories (like 10-K, ER, or IR), the most appropriate classification is the general regulatory filing category.
2020-06-09 English
Posting of Circular and Notice of General Meeting
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and is explicitly stated to be information provided by 'RNS, the news service of the London Stock Exchange.' The content announces the 'Posting of Circular and Notice of General Meeting' and directs readers to where copies are available, rather than containing the full text of the Circular or the meeting minutes itself. This structure—a brief announcement about the release of formal documents (Circular and GM notice)—fits the definition of a Report Publication Announcement (RPA). While it is a regulatory filing (RNS), RPA is more specific for announcements about the publication of other reports/notices. Given the content is an announcement about the posting of a Circular and Notice of GM, RPA is the most precise fit, although RNS is also plausible as a general category.
2020-06-08 English
Director/PDMR Shareholding
Director's Dealing Classification · 98% confidence The document begins with 'RNS Number : 0325P' and contains language typical of regulatory announcements in the UK, such as 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. The content specifically details the granting of share options to directors (CEO and CFO) and updates their total holdings. This type of filing, reporting insider transactions (director's dealing), is often disseminated via RNS. However, among the specific codes provided, 'Director's Dealing (Code: DIRS)' is the most precise fit for reporting personal share transactions by directors and executives. Although it is distributed via RNS, the core subject matter is Director's Dealing.
2020-06-04 English
Result of Fundraising
Regulatory Filings Classification · 98% confidence The document begins with 'RNS Number : 0324P' and is clearly formatted as a regulatory news service announcement from the London Stock Exchange (LSE). The content details the successful completion of a fundraising ('Result of Fundraising') which raised £48 million through the issue of new shares, including details on the use of proceeds and expected admission dates. This type of announcement, which reports a significant corporate event (fundraising/share issuance) via the official regulatory news wire, fits best under the general 'Regulatory Filings' category (RNS) as it is not a specific financial report (10-K, IR), a management discussion (MDA), or a specific capital structure change announcement like a buyback (POS) or a general share issue notice (SHA), but rather the immediate public disclosure of the completed transaction via the required channel. Given the structure and the explicit mention of RNS, RNS is the most appropriate classification.
2020-06-04 English
Increase in Fundraising
Share Issue/Capital Change Classification · 99% confidence The document begins with an 'RNS Number' and is dated June 4, 2020. The content explicitly discusses an 'Increase in Fundraising' to raise gross proceeds of £48 million through the issue of New Ordinary Shares. This clearly relates to capital raising and financing activities. While it is distributed via RNS (Regulatory News Service), the core subject matter is a capital/financing update. Therefore, the most specific classification is Capital/Financing Update (CAP). It is not a general regulatory filing (RNS) because the subject is highly specific to fundraising.
2020-06-04 English
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document is very short (1374 characters) and begins with an 'RNS Number'. The content discusses a 'Second Price Monitoring Extension' and an 'auction call period' extension related to trading on the London Stock Exchange. This is a specific, non-standard regulatory announcement concerning trading mechanics rather than a core financial report (like 10-K, ER, or IR). Since it is a direct, short announcement disseminated via the RNS system and does not fit into the specific categories like DIRS, DIV, or DLST, the most appropriate classification is the general regulatory announcement fallback category.
2020-06-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.